Zoetis | ZTS - Заемный капитал





Заемный капитал Изменить Дата
AbbVie USD 64.53B 5.59B 2026-03
Align Technology USD 0 0 2024-12
Bayer EUR 31.16B 480M 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Charles River Laboratories USD 2.62B 43.15M 2026-06
Coherus Biosciences USD 51.08M 496K 2025-12
Dentsply International USD 2B 10M 2026-06
Eli Lilly USD 47.86B 8.49B 2026-06
Henry Schein USD 2.3B 27M 2026-06
Idexx Laboratories USD 299.86M 11K 2026-06
Illumina USD 1.49B 1000K 2026-06
IQVIA Holdings USD 13.7B 284M 2026-06
J&J USD 37.34B 183M 2026-06
Laboratory Of America USD 5.92B 23.3M 2026-06
Merck USD 51.08B 4.41B 2026-06
Neogen USD 793.7M 400K 2026-03
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.28B 337.7M 2026-06
Pfizer USD 60.5B 70M 2026-06
Phibro Animal Health USD 597.68M 5.92M 2026-03
Quest Diagnostics USD 5.63B 477M 2026-06
Sanofi EUR 14.65B 806M 2026-06
Sanofi EUR 12.3B 3.42B 2026-03
Zoetis USD 9.05B 3M 2026-06